![Katharine Knobil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katharine Knobil
Director/Board Member at
MARKER THERAPEUTICS, INC.
Net worth: 236 $ as of 31/05/2026
Profile
Presently, Katharine Knobil occupies the position of Chief Medical Officer of Agilent Technologies, Inc. Dr. Knobil is also on the board of Arena Pharmaceuticals, Inc. and Member of The National Academies of Science. Dr. Knobil previously occupied the position of Chief Medical Officer, Head-Research & Development at Kaleido Biosciences, Inc. and Chief Medical Officer & Senior Vice President at GlaxoSmithKline LLC. Dr. Knobil received an undergraduate degree from Cornell University and a doctorate from The University of Texas Southwestern Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/03/2026 | 150 ( 0% ) | 236 $ | 31/05/2026 | |
-.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Katharine Knobil active positions
| Companies | Position | Start |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Director/Board Member | 08/12/2021 |
The National Academies of Science
 The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Corporate Officer/Principal | - |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Director/Board Member | - |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Chief Tech/Sci/R&D Officer | - |
Infinant Health, Inc.
 Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Director/Board Member | - |
Former positions of Katharine Knobil
| Companies | Position | End |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Director/Board Member | 11/06/2026 |
| AGILENT TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
| ARENA PHARMACEUTICALS | Director/Board Member | 11/03/2022 |
| KALEIDO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 29/01/2021 |
| ░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Katharine Knobil
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Commercial Services |
The National Health Council
 The National Health Council Miscellaneous Commercial ServicesCommercial Services Provides united voice for people with chronic diseases and disabilities and their family caregivers | Commercial Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Patient-Centered Outcomes Research Institute
 Patient-Centered Outcomes Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization to funds research that helps patients and care takers to make better decisions about their healthcare choices | Commercial Services |
Infinant Health, Inc.
Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Health Technology |
- Stock Market
- Insiders
- Katharine Knobil
